Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care

Olender, S. A., Perez, K. K., Go, A. S., Balani, B., Price-Haywood, E. G., Shah, N. S., Wang, S., Walunas, T. L., Swaminathan, S., Slim, J., Chin, B., De Wit, S., Ali, S. M., Soriano Viladomiu, A., Robinson, P., Gottlieb, R. L., Tsang, T. Y. O., Lee, I.-H., … Hu, H. (2020). Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care. Clinical Infectious Diseases, 73(11), e4166–e4174. https://doi.org/10.1093/cid/ciaa1041
Authors:
Susan A Olender
Katherine K Perez
Alan S Go
Bindu Balani
Eboni G Price-Haywood
Nirav S Shah
Su Wang
Theresa L Walunas
Shobha Swaminathan
Jihad Slim
BumSik Chin
Stéphane De Wit
Shamim M Ali
Alex Soriano Viladomiu
Philip Robinson
Robert L Gottlieb
Tak Yin Owen Tsang
I-Heng Lee
Hao Hu
Richard H Haubrich
Anand P Chokkalingam
Lanjia Lin
Lijie Zhong
B. Nebiyou Bekele
Robertino Mera-Giler
Chloé Phulpin
Holly Edgar
Joel Gallant
Helena Diaz-Cuervo
Lindsey E Smith
Anu O Osinusi
Diana M Brainard
Jose I Bernardino
Affiliated Authors:
Susan A Olender
Columbia Affiliation:
Author Keywords:
sars-cov-2
severe covid-19
remdesivir
antiviral treatment
elink
Publication Type:
Article
Unique ID:
10.1093/cid/ciaa1041
PMID:
32706859
DOI:
10.1093/cid/ciaa1041
Journal:
Clinical Infectious Diseases
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record

Record Created: